Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes by Attilio Bondanza, Veronica Valtolina, Zulma Magnani,

Slides:



Advertisements
Similar presentations
Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions by Natalie Hartmann,
Advertisements

Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation  Qing Ma, Dan Li, Roza Nurieva, Rebecca.
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease by Tangsheng Yi, Ying Chen, Lin Wang,
Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection by.
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma by Monica Casucci, Benedetta Nicolis di Robilant,
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy 
Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver  Alina Schreder,
CCR2 is required for CD8-induced graft-versus-host disease
Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell.
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Human NK cell development in NOD/SCID mice receiving grafts of cord blood CD34+ cells by Christian P. Kalberer, Uwe Siegler, and Aleksandra Wodnar-Filipowicz.
Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome by Alexander.
by Norman Nausch, Ioanna E
by Daniel L. Barber, Katrin D. Mayer-Barber, Lis R. V
Novel function for interleukin-7 in dendritic cell development
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation by Christoph Bucher, Lisa Koch, Christine.
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality by Rachelle G. Veenstra, Ryan Flynn, Katharina.
Ikaros is required for plasmacytoid dendritic cell differentiation
Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists by Christopher T.
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer.
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction by Francesca.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
by Takahiro Kamiya, Desmond Wong, Yi Tian Png, and Dario Campana
Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell–depleted stem cell transplantation.
Volume 10, Issue 1, Pages (January 2015)
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
Blocking LFA-1 Activation with Lovastatin Prevents Graft-versus-Host Disease in Mouse Bone Marrow Transplantation  Yang Wang, Dan Li, Dan Jones, Roland.
by Vladia Monsurrò, Ena Wang, Yoshisha Yamano, Stephen A
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences.
Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets by Maria Nikolova, Jean-Daniel Lelievre, Matthieu.
Evelyn C. Nieves, Tomomi Toubai, Daniel C
Volume 3, Issue 5, Pages (November 2014)
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease by Tangsheng Yi, Dongchang Zhao, Chia-Lei.
Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels  Chien-Chun Steven.
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Volume 28, Issue 4, Pages (October 2015)
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Lisa A. Palmer, George E. Sale, John I
Volume 132, Issue 1, Pages (January 2007)
Volume 33, Issue 1, Pages (July 2010)
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Volume 43, Issue 2, Pages (August 2015)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
Interleukin 17 Is Not Required for Autoimmune-Mediated Pathologic Damage during Chronic Graft-versus-Host Disease  Xiao Chen, Rupali Das, Richard Komorowski,
Volume 27, Issue 3, Pages (September 2007)
Volume 38, Issue 1, Pages (January 2013)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation  Jian-Ming Li, Edmund K.
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4+25+ T cells to allow an effective graft-versus-leukemia response 
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
Volume 5, Issue 3, Pages (September 1996)
Volume 17, Issue 2, Pages (February 2009)
by Ahmed Gehad, Jessica E. Teague, Tiago R
Volume 27, Issue 2, Pages (August 2007)
Volume 17, Issue 4, Pages (October 2002)
Donor and recipient BAL T cells are phenotypically and functionally memory T cells. Donor and recipient BAL T cells are phenotypically and functionally.
Volume 37, Issue 2, Pages (August 2012)
Volume 10, Issue 5, Pages (February 2015)
Molecular Therapy - Nucleic Acids
Presentation transcript:

Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes by Attilio Bondanza, Veronica Valtolina, Zulma Magnani, Maurilio Ponzoni, Katharina Fleischhauer, Mark Bonyhadi, Catia Traversari, Francesca Sanvito, Salvatore Toma, Marina Radrizzani, Simona La Seta-Catamancio, Fabio Ciceri, Claudio Bordignon, and Chiara Bonini Blood Volume 107(5):1828-1836 March 1, 2006 ©2006 by American Society of Hematology

Costimulation through baCD3/CD28 efficiently generates TK+ human lymphocytes with a preserved CD4/CD8 ratio. Costimulation through baCD3/CD28 efficiently generates TK+ human lymphocytes with a preserved CD4/CD8 ratio. PBMCs (5 × 106) were stimulated either with aCD3, aCD3/CD28, or baCD3/CD28. (A) After 48 hours, CD4+ (top row) or CD8+ cells (bottom row) were analyzed by flow cytometry for DNA content. The horizontal lines overlie cells in the S/M phase of the cell cycle with the relative percentages. Results with cells from one representative donor of 2 are shown. (B) At 48 and 72 hours after stimulation, cells were transduced with the RV. At day 6, TK+ cells were quantified by flow cytometry as LNGFR-expressing cells, along with staining for CD8. Quadrants were set according to isotype-control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative of 5 different donors are shown. (C) At days 6, 10, and 14, cells were counted by trypan blue exclusion and analyzed by flow cytometry. Cell counts for CD4+ (○) or for CD8+ (•) TK+ lymphocytes are reported over time. Results with cells from one representative donor of 4 are shown. Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology

Costimulation through baCD3/CD28 generates TK+ human lymphocytes with a CM phenotype. Costimulation through baCD3/CD28 generates TK+ human lymphocytes with a CM phenotype. At day 10, aCD3- or baCD3/CD28-TK+ lymphocytes were compared with the corresponding PBLs for memory phenotype. (A) After gating for CD3 in the case of PBLs and for LNGFR in the case of TK+ cells, cells were analyzed by flow cytometry for CD45RA and CCR7 expression (dot plots). Quadrants were set according to isotype-control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative donor of 5 are shown. Averages ± SD of the relative distribution of CD45RA+CCR7+, CD45RA-CCR7+, or CD45RA-CCR7- cells are reported for CD4+ (top histograms) or for CD8+ cells (lbottom histograms) in PBLs, aCD3- or baCD3/CD28-TK+ lymphocytes. (B) Cells were also analyzed by flow cytometry for CD27 and CD28 expression (dot plots). Quadrants were set according to isotype-control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative donor of 5 are shown. Averages ± SD of the relative distribution of CD28+CD27+, CD28-CD27+, or CD28-CD27- cells are reported for CD4+ (top histograms) or CD8+ cells (bottom histograms) in PBLs or saCD3- or baCD3/CD28-TK+ lymphocytes. Symbols overlying saCD3- or baCD3/CD28-TK+–related bars are for statistical comparison with the corresponding PBL-related bars (*P < .05; **P < .01; ***P < .005). Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology

baCD3/CD28-TK+ human lymphocytes are unpolarized cells that produce IL-2. baCD3/CD28-TK+ human lymphocytes are unpolarized cells that produce IL-2. At day 10, aCD3-TK+ or baCD3/CD28-TK+ lymphocytes were compared with the corresponding PBLs for cytokine production at a single cell level. (A) After gating for CD3 in the case of PBLs, and for LNGFR in the case of TK+ cells, cells were analyzed by flow cytometry for IFN-γ and IL-4 production (dot plots). Quadrants were set according to isotype-control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative donor of 4 are shown. Averages ± SD of the relative distribution of IFN-γ+IL-4+, IFN-γ-IL-4+, or IFN-γ-IL-4- are reported for CD4+ (top histograms) or CD8+ cells (lower histograms) in PBLs or aCD3- or baCD3/CD28-TK+ lymphocytes. (B) Cells were also analyzed by flow cytometry for IFN-γ and IL-2 production (dot plots). Quadrants and percentages were set according to isotype-control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative donor of 4 are shown. Averages ± SD of the relative distribution of IFN-γ+IL-2+, IFN-γ-IL-2+, or IFN-γ-IL-2- cells are reported for CD4+ (top histograms) or CD8+ cells (bottom histograms) in PBLs or aCD3- or baCD3/CD28-TK+ lymphocytes. Symbols overlying aCD3- or baCD3/CD28-TK+-related bars are for statistical comparison with the corresponding PBL-related bars (*P < .05; **P < .01; ***P < .005). Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology

baCD3/CD28-TK+ human lymphocytes lack lytic granules but strongly up-regulate CD40L on restimulation. baCD3/CD28-TK+ human lymphocytes lack lytic granules but strongly up-regulate CD40L on restimulation. At day 10, aCD3- or baCD3/CD28-TK+ lymphocytes were compared with the corresponding PBLs for CD40L up-regulation and for expression of lytic granules. (A) Before (top dot plots) and 2 hours after stimulation with PMA and ionomycin (bottom dot plots), cells were analyzed by flow cytometry for CD40L and CD8 expression after gating for CD3 in the case of PBLs and for LNGFR in the case of TK+ cells. Quadrants and percentages were set according to isotype control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative donor of 6 are shown. Curves depict averages ± SD of the proportion CD4+ cells in PBLs or aCD3- or baCD3/CD28-TK+ lymphocytes that also express CD40L over time. (B) Cells were also analyzed by flow cytometry for the expression of granzyme A (Gr-A) and perforin B (Pf-B). Quadrants and percentages were set according to isotype control staining. The inserts report the percentages of cells for each quadrant. Results with cells from one representative donor of 3 are shown. Averages ± SD of the relative distribution of GrA-PfB-, GrA+PfB-, or GrA+PfB+ in CD8+ cells from PBLs or aCD3- or baCD3/CD28-TK+ lymphocytes are reported (histograms). Symbols overlying aCD3- or baCD3/CD8-TK+–related bars are set for statistical comparison with the corresponding PBL-related symbols or bars (*P < .05; **P < .01; ***P < .005). Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology

Human purified PBLs cause lethal GvHD in NOD/scid mice in a dose-dependent fashion. Human purified PBLs cause lethal GvHD in NOD/scid mice in a dose-dependent fashion. NOD/scid mice were conditioned with anti-NK antibodies and sublethally irradiated prior to the intraperitoneal transfer of increasing numbers of human purified PBLs. (A) After infusion, mice were followed for human chimerism in peripheral blood over time. Each symbol represents a single mouse infused with 5 × 106, 10 × 106, or 20 × 106 PBLs. (B) Mice were also followed for weight loss over time. Each line represents a single mouse infused with 5 × 106, 10 × 106, or 20 × 106 PBLs. Results from mice infused with cells from one representative donor of 2 are shown. All mice with severe GvHD, defined weight loss greater than 5% (solid horizontal line in panel B) concomitant with human chimerism greater than 10% (solid horizontal line in panel A) died before week 8. (C) Spleen, liver, and gut were excised from dying animals and analyzed by histopathology after staining with hematoxylin and eosin (top row). Tissue samples were simultaneously analyzed by immunohistochemistry after counterstaining with human monoclonal anti-CD3 antibodies and peroxidase-conjugated second-step reagent (bottom row). Sections from one representative of 18 analyzed animals are shown. Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology

baCD3/CD28-TK+ human lymphocytes induce severe GvHD in NOD/scid mice. baCD3/CD28-TK+ human lymphocytes induce severe GvHD in NOD/scid mice. NOD/scid mice were conditioned, infused intraperitoneally with 20 × 106 PBLs or aCD3- or baCD3/CD28-TK+ lymphocytes and followed for human chimerism and incidence of severe GvHD. (A) Human chimerism was assessed weekly by flow cytometry after staining for human CD3 and mouse CD45. Quadrants and percentages were set according to isotype control staining. The inserts report the percentages of cells for each quadrant. Results from a single representative mouse per condition are shown over weeks 1, 2, and 4. (B) At week 1, engrafting cells were analyzed by flow cytometry for CD8 and CD4 or LNGFR expression (top dot plots). After gating for CD3, cells were also analyzed for CD45RA and CCR7 expression (middle dot plots) or for CD27 and CD28 expression (bottom dot plots). Quadrants and percentages were set according to isotype-control staining. The inserts report the percentages of cells for each quadrant. Results from a single representative mouse per condition are shown. (C) Mice were followed for severe GvHD-free survival over time. Severe GvHD was defined as weight loss greater than 5% concomitant to human chimerism greater than 10%. In the study 25 mice were infused with PBLs, 27 with aCD3/CD28-TK+, and 27 with baCD3/CD28-TK+ lymphocytes. Cells were derived from 7 human donors. For overall results on engraftment and incidence of severe GvHD, see Table 1. Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology

Ganciclovir administration rescues NOD/scid mice from severe GvHD induced by baCD3/CD28-TK+ human lymphocytes. Ganciclovir administration rescues NOD/scid mice from severe GvHD induced by baCD3/CD28-TK+ human lymphocytes. At the time of severe GvHD, NOD/scid mice were treated with GCV or with saline. (A) Individual recipients of PBL (left graphs) or baCD3/CD28-TK+ lymphocytes (right graphs) were implanted subcutaneously either with a saline-filled or a GCV-releasing osmotic pump. At days 0, 7, and 14 from the implantation of the pumps mice were assessed for human chimerism by flow cytometry (▪) and scored for GvHD by a clinical index (□, top histograms). Mice were also followed for weight loss and mortality over time (bottom curves). Open arrows indicate saline; dashed arrows, GCV administration. The broken horizontal line is set at 95%. Results from one representative mouse per condition are shown. (B) Available mice infused with PBLs (left graphs) or with baCD3/CD28-TK+ lymphocytes (right graphs) and either treated with saline or with GCV were analyzed by histopathology and scored. GCV-rescued mice were humanely killed at the end of the study, 120 days after the infusion of baCD3/CD28-TK+ cells. Each symbol represents the spleen, gut, or liver score of individual animals. (C) Histologic sections from the spleen, liver, and gut of representative animals infused with baCD3/CD28-TK+ lymphocytes and treated either with saline (top row) or with GCV (bottom row) are reported. Attilio Bondanza et al. Blood 2006;107:1828-1836 ©2006 by American Society of Hematology